All valid points Densy
BUT if PAA can file an ANZCTR Phase I for MND then they could have filed one for Covid. It's exactly the same paperwork, same pills required same exact form.... PAA have more data on MPL vs Cov than they do for MND vs MPL... that's undeniable...
Phase I escalating dose,,,, as per any other Phase I,,,,, after the Leiden data is in which is well overdue no matter where you stand and the company have had extended period to have the Phase I Trial written and Filed ready for participants....
Why the resistance to PUSH on with Covid , the other companies in that space now were working on their own Treatments and Discoveries but pivoted and applied resources in the Cov Direction , some have now received Millions in Govt Grants for Trialing.. which will be one of my Questions for the AGM
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity, page-731
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.015(7.69%) |
Mkt cap ! $93.45M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.5¢ | 19.5¢ | $459.0K | 2.222M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103700 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 127225 | 3 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |